Literature DB >> 17376009

Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement.

Howard L Fields1, Gregory O Hjelmstad, Elyssa B Margolis, Saleem M Nicola.   

Abstract

Ventral tegmental area (VTA) neuron firing precedes behaviors elicited by reward-predictive sensory cues and scales with the magnitude and unpredictability of received rewards. These patterns are consistent with roles in the performance of learned appetitive behaviors and in positive reinforcement, respectively. The VTA includes subpopulations of neurons with different afferent connections, neurotransmitter content, and projection targets. Because the VTA and substantia nigra pars compacta are the sole sources of striatal and limbic forebrain dopamine, measurements of dopamine release and manipulations of dopamine function have provided critical evidence supporting a VTA contribution to these functions. However, the VTA also sends GABAergic and glutamatergic projections to the nucleus accumbens and prefrontal cortex. Furthermore, VTA-mediated but dopamine-independent positive reinforcement has been demonstrated. Consequently, identifying the neurotransmitter content and projection target of VTA neurons recorded in vivo will be critical for determining their contribution to learned appetitive behaviors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376009     DOI: 10.1146/annurev.neuro.30.051606.094341

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  238 in total

1.  Neuronal circuits underlying acute morphine action on dopamine neurons.

Authors:  Marion Jalabert; Romain Bourdy; Julien Courtin; Pierre Veinante; Olivier J Manzoni; Michel Barrot; François Georges
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

2.  Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances.

Authors:  Zayd M Khaliq; Bruce P Bean
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 3.  Motivational Processes Underlying Substance Abuse Disorder.

Authors:  Paul J Meyer; Christopher P King; Carrie R Ferrario
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 4.  Contemporary approaches to neural circuit manipulation and mapping: focus on reward and addiction.

Authors:  Benjamin T Saunders; Jocelyn M Richard; Patricia H Janak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 5.  Arousal and drug abuse.

Authors:  Francisco J Urbano; Verónica Bisagno; Edgar Garcia-Rill
Journal:  Behav Brain Res       Date:  2017-07-17       Impact factor: 3.332

Review 6.  Establishing causality for dopamine in neural function and behavior with optogenetics.

Authors:  Elizabeth E Steinberg; Patricia H Janak
Journal:  Brain Res       Date:  2012-09-29       Impact factor: 3.252

7.  Genetic variation in the alpha synuclein gene (SNCA) is associated with BOLD response to alcohol cues.

Authors:  Claire E Wilcox; Eric D Claus; Sara K Blaine; Marilee Morgan; Kent E Hutchison
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

8.  Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling.

Authors:  Nao Chuhma; Susana Mingote; Holly Moore; Stephen Rayport
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

Review 9.  Maternally responsive neurons in the bed nucleus of the stria terminalis and medial preoptic area: Putative circuits for regulating anxiety and reward.

Authors:  Jenna A McHenry; David R Rubinow; Garret D Stuber
Journal:  Front Neuroendocrinol       Date:  2015-04-21       Impact factor: 8.606

10.  Transient inactivation of the ventral tegmental area selectively disrupts the expression of conditioned place preference for pup- but not cocaine-paired contexts.

Authors:  Katharine M Seip; Joan I Morrell
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.